Atlas Trials

Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin

Clinical trial NCT00040027 · COMPLETED

Trial details

NCT number
NCT00040027
Sponsor
SciClone Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Hepatitis CHepatitis C, Chronic
Start date
2002-04-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.